Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Quhan Zhiwang Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of rheumatoid arthritis (RA), specifically targeting the "kidney deficiency and excessive cold" syndrome, also known as Wang Bi. The decoction is designed to tonify the kidney, dispel cold, and alleviate joint pain and swelling. It is typically administered as an oral liquid preparation. In clinical research led by Liu Longxiao at Guang'anmen Hospital, the decoction is evaluated as an adjunctive treatment combined with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to help patients achieve deep remission or maintain low disease activity when standard treatments alone are insufficient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bushen quhan zhiwang decoction (Guang'anmen Hospital).